Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Ранг среди акций #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Цена акции
$183.43
Рыночная капитализация
$50.54B
Изменение (1 день)
2.13%
Изменение (1 год)
29.20%
Страна
US
Торговля Becton, Dickinson and Company (BDX)

Категория

EPS для Becton, Dickinson and Company (BDX)
EPS по состоянию на June 2026 TTM: $3.32
Согласно последним финансовым отчетам и цене акций Becton, Dickinson and Company, текущий EPS компании (TTM) составляет $3.32. В конце 2024 EPS компании составлял $5.88, больше, чем показателю 2023 года, равному $4.97.
История EPS компании Becton, Dickinson and Company с 2000 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $3.32 -43.15%
2025 $5.84 -0.68%
2024 $5.88 18.31%
2023 $4.97 -16.19%
2022 $5.93 -14.31%
2021 $6.92 151.64%
2020 $2.75 -30.56%
2019 $3.96 538.71%
2018 $0.62 -86.81%
2017 $4.70 2.40%
2016 $4.59 33.82%
2015 $3.43 -44.05%
2014 $6.13 -7.54%
2013 $6.63 18.60%
2012 $5.59 -2.78%
2011 $5.75 2.31%
2010 $5.62 9.77%
2009 $5.12 11.06%
2008 $4.61 27.00%
2007 $3.63 19.41%
2006 $3.04 5.92%
2005 $2.87 55.14%
2004 $1.85 -13.55%
2003 $2.14 15.68%
2002 $1.85 19.35%
2001 $1.55 0.65%
2000 $1.54 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$8.85 166.57%
US
$6.41 92.93%
FR
- -
JP
- -
CH
- -
US